Skip to main content
. 2015 Apr 7;6(11):8676–8686. doi: 10.18632/oncotarget.3254

Figure 3. MiR-129-5p inhibits ovarian cancer cell proliferation and survival in vitro.

Figure 3

(A) MTT assay reveals that miR-129-5p upregulation inhibits, while miR-129-5p inhibition promotes, proliferation of SKOV3 and A2780 cells. (B) Representative micrographs (left) and quantification (right) of crystal violet–stained cell colonies. (C) Representative micrographs (left) and quantification of TUNEL-positive cells in cells treated with cisplatin (20 μM) for 36 h. Scale bars: 50 μm. Each bar represents the mean of three independent experiments. *p < 0.05.